Gateway Genomics, leading developer of direct-to-consumer genetic tests that give families insight into their future children, announces a new peer-reviewed publication titled, "SneakPeek Early Gender Test: The Earliest and Most Accurate Method for Fetal Sex Determination at 6-Weeks' Gestation" in the Clinics in Mother and Child Health journal.
Gateway Genomics is a California-based biotechnology firm that develops and commercializes non-invasive prenatal and early gender DNA test kits for parents.